Knockdown of IGFBP7 Alleviates High Glucose-Triggered Vascular Endothelial Injury and Is Associated With the Upregulation of AURKA in HUVECs

Background: Progressive vascular endothelial cell (EC) injury is a key initiating event in diabetic macrovascular complications, which dramatically increases morbidity and mortality among diabetic patients by facilitating atherosclerotic lesion formation and subsequent cardio-cerebrovascular disorders. Chronic hyperglycaemia impairs endothelial proliferation, migration and angiogenic capacity; however, the key molecules regulating high glucose (HG)-mediated endothelial deterioration remain incompletely characterized. This study aimed to uncover the molecular cascade underlying HG-triggered human endothelial damage.Methods: Human umbilical vein endothelial cells (HUVECs) were randomly divided into multiple groups and incubated in medium supplemented with either physiological isotonic glucose or HG to construct an in vitro endothelial injury model induced by hyperglycaemia. Synthetic small interfering RNAs (siRNAs) were transiently transfected into HUVECs via liposomal delivery to achieve specific knockdown of insulin-like growth factor-binding protein 7 (IGFBP7) and aurora kinase A (AURKA) separately or simultaneously, with scrambled siRNA serving as the negative transfection control. After completion of drug and gene intervention, multiple sets of functional indicators (viability, migration, tube formation) and apoptotic-related molecular signatures (B-cell lymphoma 2 (Bcl-2), BCL2-associated X, apoptosis regulator (Bax), and Cleaved Caspase-3) were systematically measured to comprehensively evaluate the severity of endothelial injury.Results: HG exposure significantly impaired the fundamental biological behaviours of HUVECs, while simultaneously elevating IGFBP7 expression, depressing AURKA transcription, and tipping the equilibrium of apoptosis-related proteins: Bcl-2, Bax and Cleaved Caspase-3 (p < 0.05). Silencing IGFBP7 remarkably rescued HG-induced endothelial dysfunction, yet AURKA knockdown partly reversed these protective phenotypes (p < 0.05).Conclusion: IGFBP7 knockdown alleviates HG-induced endothelial injury, and this effect may be associated with upregulation of AURKA. These findings provide preliminary experimental evidence supporting further investigation of potential therapeutic targets for diabetic vascular complications.

Authors

Institutions

Publication Details

Journal
Discovery Medicine
Published
2026-07-23
DOI
https://doi.org/10.24976/discov.med.202638210.176
Primary Topic
Angiogenesis and VEGF in Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Knockdown of IGFBP7 Alleviates High Glucose-Triggered Vascular Endothelial Injury and Is Associated With the Upregulation of AURKA in HUVECs

Liu Zd, B A Liu, Liwei Zhang, Feng Hai
Discovery Medicine
Angiogenesis and VEGF in Cancer
article

Knockdown of IGFBP7 Alleviates High Glucose-Triggered Vascular Endothelial Injury and Is Associated With the Upregulation of AURKA in HUVECs

Liu Zd, B A Liu, Liwei Zhang, Feng Hai
article en

Abstract

Background: Progressive vascular endothelial cell (EC) injury is a key initiating event in diabetic macrovascular complications, which dramatically increases morbidity and mortality among diabetic patients by facilitating atherosclerotic lesion formation and subsequent cardio-cerebrovascular disorders. Chronic hyperglycaemia impairs endothelial proliferation, migration and angiogenic capacity; however, the key molecules regulating high glucose (HG)-mediated endothelial deterioration remain incompletely characterized. This study aimed to uncover the molecular cascade underlying HG-triggered human endothelial damage.Methods: Human umbilical vein endothelial cells (HUVECs) were randomly divided into multiple groups and incubated in medium supplemented with either physiological isotonic glucose or HG to construct an in vitro endothelial injury model induced by hyperglycaemia. Synthetic small interfering RNAs (siRNAs) were transiently transfected into HUVECs via liposomal delivery to achieve specific knockdown of insulin-like growth factor-binding protein 7 (IGFBP7) and aurora kinase A (AURKA) separately or simultaneously, with scrambled siRNA serving as the negative transfection control. After completion of drug and gene intervention, multiple sets of functional indicators (viability, migration, tube formation) and apoptotic-related molecular signatures (B-cell lymphoma 2 (Bcl-2), BCL2-associated X, apoptosis regulator (Bax), and Cleaved Caspase-3) were systematically measured to comprehensively evaluate the severity of endothelial injury.Results: HG exposure significantly impaired the fundamental biological behaviours of HUVECs, while simultaneously elevating IGFBP7 expression, depressing AURKA transcription, and tipping the equilibrium of apoptosis-related proteins: Bcl-2, Bax and Cleaved Caspase-3 (p < 0.05). Silencing IGFBP7 remarkably rescued HG-induced endothelial dysfunction, yet AURKA knockdown partly reversed these protective phenotypes (p < 0.05).Conclusion: IGFBP7 knockdown alleviates HG-induced endothelial injury, and this effect may be associated with upregulation of AURKA. These findings provide preliminary experimental evidence supporting further investigation of potential therapeutic targets for diabetic vascular complications.

Discovery MedicineVol. 38(210)
Beijing Friendship Hospital (CN)
Good health and well-being
Openalex Percentile: Top 15%
Angiogenesis and VEGF in Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.